Abstract
Risk Factors and Prognostic Scale for CMV Reactivation in CMV Seropositive Patients after Allogeneic Hematopoietic Cell Transplantation – a Single Center Cohort Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have